Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Anderson

Showing results (401-410 of 474) with videos related to

Pageof 48
Sort By:
Cancer Letters|February 1, 2025
ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastomaFederica Lorenzi, Sina Jostes, Qiong Gao, et al.
Frontiers in Oncology|February 9, 2026
Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisonsHolger N Lode, Przemysław Holko, Aleksandra Wieczorek, et al.
Science Translational Medicine|May 29, 2024
Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcomaDaniel Fowler, Marta Barisa, Alba Southern, et al.
BMJ Open Diabetes Research & Care|November 10, 2023
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort studyAbraham Olvera-Barrios, Christopher G Owen, John Anderson, et al.
The British Journal of Ophthalmology|October 24, 2023
Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effectAbraham Olvera-Barrios, Alicja R Rudnicka, John Anderson, et al.
Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.
Nature Cancer|March 26, 2021
Combined inhibition of Aurora-A and ATR kinase results in regression of <i>MYCN</i>-amplified neuroblastomaIsabelle Roeschert, Evon Poon, Anton G Henssen, et al.
Cancer Research|August 29, 2025
Phenoscaping Reveals Multimodal γδ T Cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated ImmunomodulationCallum Baird Nattress, Rhianna O'Sullivan, Daniel Fowler, et al.
Cancer Research|June 30, 2020
Noninvasive MRI Native T<sub>1</sub> Mapping Detects Response to <i>MYCN</i>-targeted Therapies in the Th-<i>MYCN</i> Model of NeuroblastomaKonstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, et al.
Computers, Informatics, Nursing : CIN|February 17, 2025
Transforming Understanding of Congenital Heart Disease Through a Virtual Reality InnovationMaria Jocelane Nascimento da Silva, Antônio Marcos de Souza Soares, Hévila Ferreira Gomes Medeiros Braga, et al.
Pageof 48

Showing results (401-410 of 474) with videos related to

Sort By:
Pageof 48
Cancer Letters|February 1, 2025
ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastomaFederica Lorenzi, Sina Jostes, Qiong Gao, et al.
Frontiers in Oncology|February 9, 2026
Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisonsHolger N Lode, Przemysław Holko, Aleksandra Wieczorek, et al.
Science Translational Medicine|May 29, 2024
Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcomaDaniel Fowler, Marta Barisa, Alba Southern, et al.
BMJ Open Diabetes Research & Care|November 10, 2023
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort studyAbraham Olvera-Barrios, Christopher G Owen, John Anderson, et al.
The British Journal of Ophthalmology|October 24, 2023
Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effectAbraham Olvera-Barrios, Alicja R Rudnicka, John Anderson, et al.
Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.
Nature Cancer|March 26, 2021
Combined inhibition of Aurora-A and ATR kinase results in regression of <i>MYCN</i>-amplified neuroblastomaIsabelle Roeschert, Evon Poon, Anton G Henssen, et al.
Cancer Research|August 29, 2025
Phenoscaping Reveals Multimodal γδ T Cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated ImmunomodulationCallum Baird Nattress, Rhianna O'Sullivan, Daniel Fowler, et al.
Cancer Research|June 30, 2020
Noninvasive MRI Native T<sub>1</sub> Mapping Detects Response to <i>MYCN</i>-targeted Therapies in the Th-<i>MYCN</i> Model of NeuroblastomaKonstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, et al.
Computers, Informatics, Nursing : CIN|February 17, 2025
Transforming Understanding of Congenital Heart Disease Through a Virtual Reality InnovationMaria Jocelane Nascimento da Silva, Antônio Marcos de Souza Soares, Hévila Ferreira Gomes Medeiros Braga, et al.
Pageof 48